Palatin Technologies, Inc. (PTN)
AMEX·Healthcare·Biotechnology
$10.70
+2.54%
Mkt Cap $291.52M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$47.50
Range $47.50 – $47.50
Implied Upside
+344.1%
Consensus $47.50 vs current $10.70
AMEX·Healthcare·Biotechnology
$10.70
+2.54%
Mkt Cap $291.52M
No recent rating data.
Price Target (3 analysts)
$47.50
Range $47.50 – $47.50
+344.1%
Consensus $47.50 vs current $10.70